Strategy for key Chilean market
Benchmark Holdings (BMK) has provided an update on its Chile salmon breeding and genetics strategy under its JV with Empresas AquaChile. The Company has the opportunity to take control of a salmon egg breeding facility owned by the JV, providing an opportunity to shape the strategy of its operations in this key geography.The underlying drivers and rationale for the strategy remain constant and particularly in view of renewed algal bloom disease challenges; meeting high demand for disease-resistant salmon produced under the most stringent biosecure conditions.
—In 2018 BMK entered a JV with Empresas AquaChile (subsequently acquired by Agrosuper) to shore up its presence and build market share in Chile, which is the second largest global producer of salmon, and harvested over 630,000 tonnes of Atlantic salmon in 2018. BMK’s equity investment of £12m for a 49% initial stake in the JV plus a £4m loan - enabled it to set up a platform in this huge and fast-growing market from a local, established land based, biosecure salmon breeding facility.
—Discussions are underway to take control of the facility which is likely to entail a return of the original £12m cash equity stake, IP rights genetic stock and biomass and resources, with the cash to be reinvested to build capacity and reinforce biosecurity. This is likely to provide BMK significant advantages overall, including the opportunity to take a dominant role in shaping the strategy of its operations in Chile, which might include the higher level of influence in cross-selling Group products and services, and potentially eventual ownership of any resulting new IP.
We make no changes to our forecasts ahead of further detail on the financial terms of the deal, but reiterate our DCF valuation of BMK stands at £585m - or 105p per share. In contrast, the c 30% 12 months fall in the share price has created a mismatch between Group valuation and forthcoming potential.
Benchmark Holdings is principally engaged in the provision of technical services, products and knowledge that support the development of sustainable food and farming industries. Co.'s reportable segments include: Animal Health Division, which provides veterinary services, environmental services diagnostics and animal health products to aquaculture, and manufactures licenced veterinary vaccines and vaccine components; Genetics Division, which harnesses salmon breeding technologies combined with production facilities to provide a range of high genetic merit ova; and Advanced Animal Nutrition, which manufactures and provides nutrition and health products to the aquaculture industry.
Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.